{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:59Z","timestamp":1740134879498,"version":"3.37.3"},"reference-count":9,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"DOI":"10.1182\/blood.2023023532","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T15:31:12Z","timestamp":1710430272000},"page":"945-947","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Systemic mastocytosis: dying or survivin"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-9875","authenticated-orcid":false,"given":"Joakim S.","family":"Dahlin","sequence":"first","affiliation":[{"name":"1Karolinska Institutet"},{"name":"2Karolinska University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-5512","authenticated-orcid":false,"given":"Gunnar","family":"Nilsson","sequence":"additional","affiliation":[{"name":"1Karolinska Institutet"},{"name":"2Karolinska University Hospital"},{"name":"3Uppsala University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"11","key":"2024031415310526500_bib1","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood.2023020515","article-title":"Tumor necrosis factor \u03b1 promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on\u00a0prognosis","volume":"143","author":"Greiner","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2024031415310526500_bib2","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"1","key":"2024031415310526500_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3324\/haematol.2018.212126","article-title":"Oncogenic D816V-KIT signaling in mast cells\u00a0causes persistent IL-6 production","volume":"105","author":"Tobio","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"2024031415310526500_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent\u00a0systemic mastocytosis patients are\u00a0associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"issue":"24","key":"2024031415310526500_bib5","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNFalpha facilitates clonal expansion\u00a0of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2024031415310526500_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.1992.tb06398.x","article-title":"Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia","volume":"80","author":"Freedman","year":"1992","journal-title":"Br J Haematol"},{"issue":"7","key":"2024031415310526500_bib7","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders. A\u00a0prospective study of the Spanish Network on\u00a0Mastocytosis (REMA) in a series of 113\u00a0patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2024031415310526500_bib8","doi-asserted-by":"crossref","first-page":"e12167","DOI":"10.1002\/clt2.12167","article-title":"Altered innate immune profile in blood of systemic mastocytosis patients","volume":"12","author":"Perez-Pons","year":"2022","journal-title":"Clin Transl Allergy"},{"unstructured":"Broad DepMap\n          . DepMap 23Q4 Public. Figshare+. Dataset; 2023. Accessed 13 December 2023. https:\/\/doi.org\/10.25452\/figshare.plus.24667905.v1.","key":"2024031415310526500_bib9"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/11\/945\/2218039\/blood_bld-2023-023532-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/11\/945\/2218039\/blood_bld-2023-023532-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T15:31:20Z","timestamp":1710430280000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/11\/945\/515210\/Systemic-mastocytosis-dying-or-survivin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,3,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023023532","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}